Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

PULSE BIOSCIENCES, INC. (PLSE)

$53.02 +0.65% NASDAQ: PLSE · 15-min delayed
  • HAYWARD, California
  • Public · NASDAQ: PLSE
  • 116 employees
$2.1BMarket cap
$350.0KRevenue · FY2025
-$72.8MNet income
116Employees
PLSENASDAQ
2016IPO

About PULSE BIOSCIENCES, INC.

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$350.0K
Net income
-$72.8M
Total assets
$94.5M
Market cap
$2.1B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: PLSE
$53.02 +0.65%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$12.66 $55.20

52-week range

Market cap
$2.1B
Shares outstanding
39.5M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
May 18, 2016

Pulse Biosciences, Inc. (PLSE) Stock Price

  • Reported a net loss of $72.8M in FY2025.
  • Trading 4% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review PULSE BIOSCIENCES, INC..

Write a review
Newsroom

News about PULSE BIOSCIENCES, INC.

News & sentiment via Polygon.io

FAQ

Pulse Biosciences, Inc.: frequently asked questions

Is Pulse Biosciences, Inc. an American company?

Pulse Biosciences, Inc. is a US-based company headquartered in Hayward, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Pulse Biosciences, Inc. headquartered?

Pulse Biosciences, Inc. is headquartered in Hayward, California, United States.

Is Pulse Biosciences, Inc. publicly traded?

Yes — Pulse Biosciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol PLSE on the NASDAQ.

What does Pulse Biosciences, Inc. do?

Pulse Biosciences, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →